Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease

J. Herberth, A. Fahrleitner-Pammer, B. Obermayer-Pietsch, P. Krisper, H. Holzer, H. H. Malluche, H. Dobnig

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Introduction: Loss of renal function is accompanied by progressive increase in serum levels of intact parathyroid hormone (iPTH) in patients with end-stage renal disease (ESRD). There is a paucity of data regarding levels of PTH-(1-84) and its large carboxyl-terminal fragments (large C-PTH fragments) and progressive loss of kidney function in patients with chronic kidney disease (CKD). The current study was undertaken to describe the glomerular filtration rate (GFR)-dependent plasma concentrations of PTH-(1-84) and related large C-PTH fragments in adult patients with CKD by using different commercially available PTH assays. Methods: We studied 80 Caucasian patients with CKD stages 1 - 5 without renal replacement therapy. Creatinine clearance was calculated by the Modification of Diet in Renal Disease (MDRD) formula. Levels of iPTH were determined by second-generation assays (iPTH Elecsys® system, Roche Diagnostics; DUO total iPTH, Scantibodies Laboratory, Inc.; iPTH, Nichols Institute Diagnostics). Third-generation assays were used to measure PTH-(1-84) (CAP (cyclase activating PTH), Scantibodies; Bio-Intact PTH, Nichols). Levels of large C-PTH fragments and ratios of PTH-(1-84)/large C-PTH fragments were calculated and statistical analyses performed. Results: Levels of iPTH and PTH-(1-84) showed CKD s tage-dependent increases. Variations among the assays increased with progressive loss of kidney function. The assay from Scantibodies showed a GFR-dependent decrease of the ratio 1-84 PTH/large C-PTH fragment that was not observed with the Nichols assay. Conclusion: Increasing variations amon g the assays with progression of CKD emphasize the fact that the interpretation of measurements must take into consideration the specific assay. We found evidence for a possible preferential increase of the level of large C-PTH fragments over 1-84 PTH in a CKD stage-dependent manner (Scantibodies). The clinical implications of this finding have to be further evaluated by bone biopsy studies.

Original languageEnglish
Pages (from-to)328-334
Number of pages7
JournalClinical Nephrology
Issue number5
StatePublished - May 2006


  • Bio-intact PTH
  • Chronic kidney disease
  • PTH assays
  • PTH-(1-84), large C-PTH fragments
  • Parathyroid hormone
  • Total PTH, intact PTH

ASJC Scopus subject areas

  • Nephrology


Dive into the research topics of 'Changes in total parathyroid hormone (PTH), PTH-(1-84) and large C-PTH fragments in different stages of chronic kidney disease'. Together they form a unique fingerprint.

Cite this